An Incisive, In-depth Analysis on the Cytotoxic Drugs Market
This study offers a comprehensive, 360 degree analysis on the Cytotoxic Drugs market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Cytotoxic Drugs market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Cytotoxic drugs are being used as a potent drug in cancer treatment. Cytotoxic drugs are also used in developing ADCs (antibody-drug conjugates): There are two types of cytotoxic agents available currently, one is DNA modifying agents and the other is microtubule disrupting agents which effects the cell cycle in order restrict them to multiply and unlike drugs of category which are cell life cycle specific, DNA modifying agents kill cells at any point.
Cytotoxic Drugs included in the report are products that are used for cancer treatment and research. The growth of the global Cytotoxic Drugs market is primarily driven by increasing prevalence of cancer indications, rising population prescribed with chemotherapy, awareness programs conducted by public and private associations, and other socio-economic factors. In terms of revenue, cytotoxic drugs segmented as antimetabolites are estimated dominated the global market in drug type category with over two third revenue share in recent years.
Generic Cytotoxic Drugs industry is more accessible to new players given fragmented nature of the cytotoxic drug market in emerging economies. Generic version of cytotoxic drugs are more affordable and easily available among patient population in low income settings. Physicians in developed market however are opting for branded Cytotoxic Drugs due to positive outcomes in commercial usage. This boosts revenue generation for the leading manufacturers of branded cytotoxic drugs. Stringent regulations observed globally for cytotoxic drugs is a factor expected to hamper the revenue growth of the global Cytotoxic Drugs market over the forecast period.
In the drug type category for cytotoxic drugs, antimetabolites is the leading segment with most of the market share by value and volume. Others section is leading due to the inclusion of many types like metal salts, topoisomerase ii inhibitors, enzyme and more.
The global Cytotoxic Drugs market is estimated to expand at a CAGR of 0.9% over the forecast period of 2018 – 2028 to reach value of over US$ 17 Bn at the end of 2028. A significant drawback of the cytotoxic drugs market is manufacturers not filing for regulatory approval; delays or denials of approval; or, manufacturers awaiting the results of reimbursement negotiations prior to launching the drug in the country, etc. These factors cumulatively contribute towards cytotoxic drugs not being available in most of the countries or suffering critical shortage. Less than 20% of the entire gamut of cytotoxic drugs are available in most of the pharma emerging markets.
Geographically, the global Cytotoxic Drugs market is segmented into eight major regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific (Asia-Pacific excluding China & Japan), China, Japan and Middle East & Africa (MEA). In terms of value, North America is expected to be the dominant regional market for Cytotoxic Drugs by 2018 end and is expected to expand at a healthy CAGR over the forecast period. Asia Pacific excluding China and Japan is expected to witness significant growth in the global Cytotoxic Drugs market over the forecast period. Europe is expected to grow in the global Cytotoxic Drugs market due to increasing demand for premium-priced products and favorable conditions for cancer care. Also, increasing number of specialty programs will lead to increased access to cytotoxic drugs. APECJ cytotoxic drugs market is estimated to reflect impressive growth due to expanding patient volume and price cutting.
Examples of some of the key players operating in the Cytotoxic Drugs market include Sanofi, Pfizer, Novartis AG, Johnson and Johnson, F. Hoffmann-La Roche AG, Lonza, Celgene Corp., Amgen Inc. , GlaxoSmithKline PLC, Merck & Co., Inc., Eli Lilly and Company and Teva Pharmaceutical.
Cytotoxic Drugs is one of the most prominent segment for medications in cancer care. Technological advancements helps cytotoxic drugs market revenue to grow and to share the trend. Cytotoxic drugs are highly hazardous in nature. The growth of the cytotoxic drugs market is also related to the growing number of CDMOs, which play a vital role in the production of selective cytotoxic drugs. Manufacturing environment for cytotoxic drugs needs to be regulated, companies prefer to ask service from CDMOs and for the preparing combination drugs in larger amount. And with the increasing number of cancer cases, cytotoxic drugs will still find demand. It is expected to fuel the revenue growth of the cytotoxic drugs market. Furthermore, to understand the market correctly, the cytotoxic drugs market report is categorically split into three sections viz. market analysis by product type, by drug type, by route of administration, end users and regions.
The growth of the Cytotoxic Drugs market is dependent on various factors such as increased funding in cancer research, awareness campaigns by governments, etc. Similarly, manufacturing hazard associated with cytotoxic drugs makes it a rather open and diverse market for the manufacturers and potential distributors, with stable demand. The key players in the Cytotoxic Drugs market are particularly focusing on inorganic routes such as acquisitions, mergers, expansion, and adoption of new technologies in licensing.
The global cytotoxic drugs market has been segmented based on:
- Product Type
- Drug Type
- Route Of Administration
- End User
The Cytotoxic Drugs report analyses the global Cytotoxic Drugs market in terms of value (US$). The Cytotoxic Drugs Market report begins with the market definition and overview explaining different market segments. Recent developments and major trends in the Cytotoxic Drugs market enable to identify the overall market scenario in various regions with the analysis of historical evolution of Cytotoxic Drugs in the market and possible future growth opportunities. The Cytotoxic Drugs market dynamics section includes company’s analyses on key trends, drivers, restraints, opportunities and macro factors influencing the global market. Impact analysis of key growth drivers and restraints of the Cytotoxic Drugs Market based on weighted average model has also been included in the report to better equip clients with crystal clear decision-making insights.
The report analyses the global Cytotoxic Drugs market based on the regions and presents the forecast in terms of value for the next 10 years. The regions covered in the report include:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Middle East & Africa
The report analyses the global Cytotoxic Drugs market based on the product type and presents the forecast in terms of value for the next 10 years. The product types covered in the report include:
- Branded Drugs
- Generic Drugs
The report analyses the global Cytotoxic Drugs market based on the drug type segment and presents the forecast in terms of value for the next 10 years. The drug type covered in the report include:
- Alkylating Agents
- Antitumor Antibiotics
- Plant Alkaloids
The report analyses the global Cytotoxic Drugs market based on the Route of Administration segment and presents the forecast in terms of value for the next 10 years. The Route of Administration covered in the report include:
The report analyses the global Cytotoxic Drugs market based on the End User segment and presents the forecast in terms of value for the next 10 years. The End User covered in the report include:
- Cancer Research Center
- Drug Testing Laboratory
In addition, we have taken into consideration the year-on-year growth and incremental $ opportunity to understand the predictability of the market and to identify the right growth opportunities in the global Cytotoxic Drugs market.
Another key feature of this Cytotoxic Drugs report is the analysis of key segments in terms of market attractiveness index. This is the combination of market share index and CAGR of an individual segment and it provides the incremental opportunity of particular segment in the overall Cytotoxic Drugs market. This parameter is very critical for assessing the level of opportunity that a player in the Cytotoxic Drugs market can look to achieve, as well as to identify potential resources from the sales and delivery perspective of the products. The resulting index helps client to identify real market opportunities in Cytotoxic Drugs Market.
In the final section of the report on the global Cytotoxic Drugs market, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to Cytotoxic Drugs segment in the Cytotoxic Drugs market and participants across the value chain associated with cytotoxic drugs. Moreover, this section also includes market strategies and SWOT analysis of the major players in the global Cytotoxic Drugs market.
Detailed profiles of the providers of Cytotoxic Drugs are also included in the scope of the report to evaluate their long- and short-term strategies. Examples of some of the key players in the global Cytotoxic Drugs market are Sanofi, Pfizer, Novartis AG, Johnson and Johnson, F. Hoffmann-La Roche AG, Lonza, Celgene Corp., Amgen Inc. , GlaxoSmithKline PLC, Merck & Co., Inc., Eli Lilly and Company and Teva Pharmaceutical.